Febuvas 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing serum uric acid levels. Lowering uric acid helps prevent gout attacks, tophi formation, and kidney complications associated with chronic hyperuricemia. Febuvas 40 is typically prescribed for adults who have not responded adequately to other urate-lowering therapies or who are intolerant to allopurinol. It is important to take this medication exactly as directed by a healthcare professional, usually once daily, with or without food. Patients should maintain adequate hydration during treatment to help prevent kidney stones. Common side effects may include nausea, joint pain, rash, and liver enzyme abnormalities; therefore, periodic monitoring of liver function tests is recommended. Febuvas 40 is contraindicated in patients with severe liver impairment or hypersensitivity to Febuxostat. It is essential to inform your doctor about any other medications being taken to avoid potential drug interactions. Always consult a healthcare provider before starting or stopping Febuvas 40 to ensure safe and effective treatment of gout and hyperuricemia.